Recent insider trading activity from Currie Graeme Martin, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2024 | Pasithea Therapeutics Corp. | $KTTA | Currie Graeme Martin | Chief Development Officer | A | Stock Option (right to buy) | 5938 | $0.00 | 5,938.0000 | 1,226,600 | 9999.99% | 0.48% |
| March 1, 2024 | Pasithea Therapeutics Corp. | $KTTA | Currie Graeme Martin | Chief Development Officer | A | Stock Option (right to buy) | 5938 | $0.00 | 5,938.0000 | 1,226,600 | 9999.99% | 0.48% |